Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marangolo

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow TransplantationS Leyvraz, L Perey, G Rosti, et al.
The International Journal of Biological Markers|October 1, 1990
Radioimmunotherapy trials in germ testicular carcinoma: a phase I studyP Riva, M Marangolo, V Tison, et al.
Bone Marrow Transplantation|July 15, 2003
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast cancerU De Giorgi, G Rosti, A Zaniboni, et al.
Bone Marrow Transplantation|July 1, 1989
High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot studyM Marangolo, G Rosti, D Amadori, et al.
Tumori|March 1, 1996
[High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors]G Rosti, P Ferrante, A Tienghi, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Primary gastric lymphoma: a review of 45 casesA Ravaioli, M Amadori, M Faedi, et al.
Bone Marrow Transplantation|August 28, 2003
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999P Pedrazzoli, P Ferrante, A Kulekci, et al.
Leukemia & Lymphoma|August 1, 1994
Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR)E Pasquini, M Nicolini, G Rosti, et al.
Clinical Orthopaedics and Related Research|September 1, 1991
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremitiesG Bacci, P Picci, G Pignatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasoneF Roila, M Tonato, F Cognetti, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow TransplantationS Leyvraz, L Perey, G Rosti, et al.
The International Journal of Biological Markers|October 1, 1990
Radioimmunotherapy trials in germ testicular carcinoma: a phase I studyP Riva, M Marangolo, V Tison, et al.
Bone Marrow Transplantation|July 15, 2003
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast cancerU De Giorgi, G Rosti, A Zaniboni, et al.
Bone Marrow Transplantation|July 1, 1989
High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot studyM Marangolo, G Rosti, D Amadori, et al.
Tumori|March 1, 1996
[High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors]G Rosti, P Ferrante, A Tienghi, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Primary gastric lymphoma: a review of 45 casesA Ravaioli, M Amadori, M Faedi, et al.
Bone Marrow Transplantation|August 28, 2003
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999P Pedrazzoli, P Ferrante, A Kulekci, et al.
Leukemia & Lymphoma|August 1, 1994
Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR)E Pasquini, M Nicolini, G Rosti, et al.
Clinical Orthopaedics and Related Research|September 1, 1991
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremitiesG Bacci, P Picci, G Pignatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasoneF Roila, M Tonato, F Cognetti, et al.
Pageof 11